Deborah Persaud

7.3k total citations · 1 hit paper
80 papers, 3.9k citations indexed

About

Deborah Persaud is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Deborah Persaud has authored 80 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Infectious Diseases, 59 papers in Virology and 18 papers in Epidemiology. Recurrent topics in Deborah Persaud's work include HIV Research and Treatment (59 papers), HIV/AIDS Research and Interventions (52 papers) and HIV/AIDS drug development and treatment (40 papers). Deborah Persaud is often cited by papers focused on HIV Research and Treatment (59 papers), HIV/AIDS Research and Interventions (52 papers) and HIV/AIDS drug development and treatment (40 papers). Deborah Persaud collaborates with scholars based in United States, South Africa and India. Deborah Persaud's co-authors include Robert F. Siliciano, Joel N. Blankson, Carrie Ziemniak, Katherine Luzuriaga, Stuart C. Ray, Janet D. Siliciano, Thomas C. Quinn, Ya Hui Chen, Douglas D. Richman and William J. Moss and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Blood.

In The Last Decade

Deborah Persaud

76 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant

2013 385 citations Deborah Persaud, Hannah Gay et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah Persaud United States	29	2.9k	2.7k	705	678	403	80	3.9k
Hans‐Jürgen Stellbrink Germany	30	1.9k 0.6×	2.3k 0.8×	1.0k 1.4×	404 0.6×	945 2.3×	74	3.7k
Jan Gerstoft Denmark	33	1.6k 0.6×	1.3k 0.5×	895 1.3×	1000 1.5×	537 1.3×	97	3.0k
Harry E. Prince United States	33	1.2k 0.4×	1.7k 0.6×	1.1k 1.6×	1.5k 2.1×	180 0.4×	124	4.1k
Ann Chahroudi United States	29	1.5k 0.5×	1.0k 0.4×	999 1.4×	1.6k 2.3×	170 0.4×	101	3.3k
Frank de Wolf Netherlands	33	3.1k 1.1×	2.5k 0.9×	1.1k 1.6×	1.1k 1.7×	514 1.3×	67	4.4k
Charles Farthing United States	22	3.0k 1.0×	1.9k 0.7×	1.1k 1.5×	1.7k 2.5×	256 0.6×	46	4.0k
Mariza Gonçalves Morgado Brazil	31	2.5k 0.8×	2.5k 0.9×	1.0k 1.5×	560 0.8×	175 0.4×	164	3.7k
Suzanne Jurriaans Netherlands	39	3.5k 1.2×	3.7k 1.3×	1.7k 2.5×	888 1.3×	646 1.6×	128	5.6k
A S Fauci United States	34	3.4k 1.2×	2.1k 0.8×	1.2k 1.7×	2.3k 3.4×	320 0.8×	52	5.1k
Assan Jaye Gambia	33	1.2k 0.4×	1.3k 0.5×	891 1.3×	1.0k 1.5×	228 0.6×	81	2.8k

Countries citing papers authored by Deborah Persaud

Since Specialization

Citations

This map shows the geographic impact of Deborah Persaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Persaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Persaud more than expected).

Fields of papers citing papers by Deborah Persaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Persaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Persaud. The network helps show where Deborah Persaud may publish in the future.

Co-authorship network of co-authors of Deborah Persaud

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Persaud. A scholar is included among the top collaborators of Deborah Persaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Persaud. Deborah Persaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andargie, T., Oren Gordon, Yi Wang, et al.. (2024). Emergency Myelopoiesis Distinguishes Multisystem Inflammatory Syndrome in Children From Pediatric Severe Coronavirus Disease 2019. The Journal of Infectious Diseases. 230(2). e305–e317.

Pascucci, Giuseppe Rubens, Francesca Rocchi, Chiara Pighi, et al.. (2023). How CD4+ T Cells Transcriptional Profile Is Affected by Culture Conditions: Towards the Design of Optimal In Vitro HIV Reactivation Assays. Biomedicines. 11(3). 888–888. 1 indexed citations

Tierney, Camlin, Deborah Persaud, Jennifer Jao, et al.. (2022). Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life. Clinical Infectious Diseases. 76(3). e744–e747. 2 indexed citations

Duff, Yann Le, Priyanka Uprety, Cheryl Jennings, et al.. (2021). Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials. Journal of Clinical Virology. 139. 104822–104822. 10 indexed citations

Berendam, Stella J., Ashley N. Nelson, Ria Goswami, et al.. (2020). Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure. Current HIV/AIDS Reports. 17(3). 237–248. 10 indexed citations

Hsu, Jingmei, Marshall J. Glesby, Tsiporah B. Shore, et al.. (2018). CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational Study. Blood. 132(Supplement 1). 2184–2184.

Chahroudi, Ann, Thor A. Wagner, & Deborah Persaud. (2018). CNS Persistence of HIV-1 in Children: the Untapped Reservoir. Current HIV/AIDS Reports. 15(5). 382–387. 9 indexed citations

Koay, Wei Li Adeline, et al.. (2017). The microbiome and HIV persistence. Current Opinion in HIV and AIDS. 13(1). 61–68. 42 indexed citations

Shivakoti, Rupak, Amita Gupta, Priyanka Uprety, et al.. (2015). Soluble CD14: An Independent Biomarker for the Risk of Mother-to-Child Transmission of HIV in a Setting of Preexposure and Postexposure Antiretroviral Prophylaxis. The Journal of Infectious Diseases. 213(5). 762–765. 7 indexed citations

10.

King, Caroline C., Athena P. Kourtis, Deborah Persaud, et al.. (2015). Delayed HIV detection among infants exposed to postnatal antiretroviral prophylaxis during breastfeeding. AIDS. 29(15). 1953–1961. 21 indexed citations

11.

Persaud, Deborah, Hannah Gay, Carrie Ziemniak, et al.. (2013). Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant. New England Journal of Medicine. 369(19). 1828–1835. 385 indexed citations breakdown →

12.

Persaud, Deborah, Paul Palumbo, Carrie Ziemniak, et al.. (2012). Dynamics of the resting CD4+ T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age. AIDS. 26(12). 1483–1490. 69 indexed citations

13.

Bertagnolio, Silvia, Martina Penazzato, Michael R. Jordan, et al.. (2012). World Health Organization Generic Protocol to Assess Drug-Resistant HIV Among Children <18 Months of Age and Newly Diagnosed With HIV in Resource-Limited Countries. Clinical Infectious Diseases. 54(suppl_4). S254–S260. 17 indexed citations

14.

Kuhn, Louise, Ashraf Coovadia, Renate Strehlau, et al.. (2012). Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial. The Lancet Infectious Diseases. 12(7). 521–530. 45 indexed citations

15.

Gautney, Brad, et al.. (2011). Analysis of the optimal cut-point for HIV-p24 antigen testing to diagnose HIV infection in HIV-exposed children from resource-constrained settings. Journal of Clinical Virology. 50(4). 338–341. 3 indexed citations

16.

Agwu, Allison L., Jane C. Lindsey, Kimberly Ferguson, et al.. (2008). Analyses of HIV-1 Drug-Resistance Profiles Among Infected Adolescents Experiencing Delayed Antiretroviral Treatment Switch After Initial Nonsuppressive Highly Active Antiretroviral Therapy. AIDS Patient Care and STDs. 22(7). 545–552. 19 indexed citations

17.

Persaud, Deborah, Stuart C. Ray, Aima A. Ahonkhai, et al.. (2007). Slow Human Immunodeficiency Virus Type 1 Evolution in Viral Reservoirs in Infants Treated with Effective Antiretroviral Therapy. AIDS Research and Human Retroviruses. 23(3). 381–390. 51 indexed citations

18.

Nettles, Richard E., Tara L. Kieffer, Joseph Cofrancesco, et al.. (2004). Genotypic Resistance in HIV‐1–Infected Patients with Persistently Detectable Low‐Level Viremia while Receiving Highly Active Antiretroviral Therapy. Clinical Infectious Diseases. 39(7). 1030–1037. 59 indexed citations

19.

Persaud, Deborah, Theodore C. Pierson, Christian T. Ruff, et al.. (2000). A stable latent reservoir for HIV-1 in resting CD4+ T lymphocytes in infected children. Journal of Clinical Investigation. 105(7). 995–1003. 140 indexed citations

20.

Blankson, Joel N., Deborah Persaud, & Robert F. Siliciano. (1999). Latent reservoirs for HIV-1. Current Opinion in Infectious Diseases. 12(1). 5–11. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact